Here, we discovered that Sema6d deficiency suppressed tumor progression via increased cytotoxic CD8+ T cell infiltration into tumors in a murine oral cancer model using MOC2 cells without endogenous Sema6d expression. The gene discussed is CD8A; the disease is neoplasm.